Hypertrophic Cardiomyopathy in Review: Highlights from HFA 2021
Published: 06 October 2021
-
Views:
2245
-
Likes:
7
-
Views:
2245
-
Likes:
7
-
Up Next -
6m 48sPart 1 | Session 2 Identifying Patients who Benefit from Invasive Procedures -
6m 59sPart 1 | Session 3 Stratifying Individuals for Further Investigation or Genetic Testing
Overview
In this video series, Prof Perry Elliott presents a wrap-up following the HFA 2021 around hypertrophic cardiomyopathy.
More from this programme
Part 1
Hypertrophic Cardiomyopathy in Review
Faculty Biographies
Perry Elliott
Professor in Inherited Cardiovascular Disease
Personal History
Professor Perry Mark Elliott was born on December 7, 1963, in London.6 He is a Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR).
He is Director of the UCL Centre for Heart Muscle Disease, Head of Clinical Research at the Institute of Cardiovascular Science UCL and a consultant cardiologist in the Centre for Inherited Cardiovascular Disease at the Barts Heart Centre, St. Bartholomew's Hospital London, UK.3
Academic History1
Dr Elliott studied medicine at St. Thomas’s Hospital Medical School, London from 1982 to 1987.
After graduating in 1987 he trained in general medicine. In 1991 he became a member of the Royal College of Physicians and completed his general cardiology training at St. George’s Hospital Medical School, London.
His…